Down-regulation of the dopamine receptor D2 in mice lacking ataxin 1

Human Molecular Genetics

Volumn 16, Issue 17, 2007, Pages 2122-2134

  Goold, Robert ^a   Hubank, Michael ^a   Hunt, Abigail ^a   Holton, Janice ^b   Menon, Rajesh P ^c   Revesz, Tamas ^b   Pandolfo, Massimo ^d   Matilla Dueñas, Antoni ^a,e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^d ERASME HOSPITAL   (Belgium)

^e HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 1; DOPAMINE 2 RECEPTOR; LUCIFERASE; POLYGLUTAMINE; RETINOIC ACID; THYROID HORMONE; TRANSCRIPTION FACTOR SP1; WNT PROTEIN; ZINC FINGER PROTEIN;

ANIMAL CELL; ARTICLE; BRAIN STEM; CEREBELLAR ATAXIA; CEREBELLUM; CONTROLLED STUDY; DEGENERATIVE DISEASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; IN VIVO STUDY; MICROARRAY ANALYSIS; MOTOR DYSFUNCTION; MOUSE; NEUROBLASTOMA CELL; NEUROPATHY; NONHUMAN; OPHTHALMOPLEGIA; PATHOGENICITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PURKINJE CELL; RECEPTOR DOWN REGULATION; RECEPTOR OCCUPANCY; SIGNAL TRANSDUCTION; SPINOCEREBELLAR DEGENERATION; SPINOCEREBELLAR TRACT; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

ANIMALS; CEREBELLUM; HUMANS; MALE; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); RECEPTORS, DOPAMINE D2; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

MUS; MUS MUSCULUS;

EID: 34548452053     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm162     Document Type: Article

References (56)

1. Zoghbi, H.Y. and Orr, H.T. (2001) Spinocerebellar ataxias. In Scriver, C.R., Sly, W.S., Childs, A.L., Beaudet, A.L., Valle, D., Kinzler, K.W. and Volgestein, B. (eds), The Metabolic and Molecular Basis of Inherited Disease, MaGraw Professionals, New York, pp. 5741-5758.
2. Matilla-Dueñas, A., Goold, R. and Giunti, P. (2006) Molecular pathogenesis of spinocerebellar ataxias. Brain, 129, 1357-1370.
3. Orr, H., Chung, M.-Y., Banfi, S., Kwiatkowski, T.J. Jr, Servadio, A., Beaudet, A.L., McCall, A.E., Duvick, L.A., Ranum, L.P.W. and Zoghbi, H.Y. (1993) Expansion of an unstable trinucleotide (CAG) repeat in spinocerebellar ataxia type 1. Nature Genet., 4, 221-226.
4. Gatchel, J.R. and Zoghbi, H.Y. (2005) Diseases of unstable repeat expansion: Mechanisms and common principles. Nat. Rev. Genet., 6, 743-755.
5. Matilla, A., Roberson, E.D., Banfi, S., Morales, J., Armstrong, D.L., Burright, E.N., Orr, H.T., Sweatt, J.D., Zoghbi, H.Y. and Matzuk, M.M. (1998) Mice lacking ataxin-1 display learning deficits and decreased hippocampal paired-pulse facilitation. J. Neurosci., 18, 5508-5516.
6. Mushegian, A.R., Bassett, D.E. Jr, Boguski, M.S., Bork, P. and Koonin, E.V. (1997) Positionally cloned human disease genes: Patterns of evolutionary conservation and functional motifs. Proc. Natl Acad. Sci. USA, 94, 5831-5836.
7. de Chiara, C., Giannini, C., Adinolfi, S., de Boer, J., Guida, S., Ramos, A., Jodice, C., Kioussis, D. and Pastore, A. (2003) The AXH module: An independently folded domain common to ataxin-1 and HBP1. FEBS Lett., 551, 107-112.
8. Chen, H.K., Fernandez-Funez, P., Acevedo, S.F., Lam, Y.C., Kaytor, M.D., Fernandez, M.H., Aitken, A., Skoulakis, E.M., Orr, H.T., Botas, J. et al. (2003) Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell, 113, 457-468.
9. Emamian, E.S., Kaytor, M.D., Duvick, L.A., Zu, T., Tousey, S.K., Zoghbi, H.Y., Clark, H.B. and Orr, H.T. (2003) Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron, 38, 375-387.
10. Tsuda, H., Jafar-Nejad, H., Patel, A.J., Sun, Y., Chen, H.K., Rose, M.F., Venken, K.J.,. Botas, J., Orr, H.T., Bellen, H.J. et al. (2005) The AXH domain of Ataxin-1 mediates neurodegeneration through its interaction with Gfi-1/Senseless proteins. Cell, 122, 633-644.
11. Lin, X., Antalffy, B., Kang, D., Orr, H.T. and Zoghbi, H.Y. (2000) Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1. Nat. Neurosci., 3, 157-163.
12. Serra, H.G., Byam, C.E., Lande, J.D., Tousey, S.K., Zoghbi, H.Y. and Orr, H.T. (2004) Gone profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice. Hum. Mol. Genet., 13, 2535-2543.
13. Matilla, A., Koshy, B.T., Cummings, C.J., Isobe, T., Orr, H.T. and Zoghbi, H.Y. (1997) The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature, 389, 974-978.
14. Okazawa, H., Rich, T., Chang, A., Lin, X., Waragai, M., Kajikawa, M., Enokido, Y., Komuro, A., Kato, S., Shibata, M. et al. (2002) Interaction between mutant ataxin-1 and PQBP-1 affects transcription and cell death. Neuron, 34, 701-713.
15. Tsai, C.C., Kao, H.Y., Mitzutani, A., Banayo, E., Rajan, H., McKeown, M. and Evans, R.M. (2004) Ataxin 1, a SCA1 neurodegenerative disorder protein, is functionally linked to the silencing mediator of retinoid and thyroid hormone receptors. Proc. Natl Acad. Sci. USA, 101 4047-4052.
16. Mizutani, A., Wang, L., Rajan, H., Vig, P.J., Alaynick, W.A., Thaler, J.P. and Tsai, C.C. (2005) Boat, an AXH domain protein, suppresses the cytotoxicity of mutant ataxin-1. EMBO J., 24, 3339-3351.
17. Lam, Y.C., Bowman, A.B., Jafar-Nejad, P., Lim, J., Richman, R., Fryer, J.D., Hyun, E.D., Duvick, L.A., Orr, H.T., Botas, J. et al. (2006) ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Cell, 127, 1335-1347.
18. Serra, H.G., Duvick, L., Zu, T., Carlson, K., Stevens, S., Jorgensen, N., Lysholm, A., Burright, E., Zoghbi, H.Y., Clark, H.B. et al. (2006) RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice. Cell, 127, 697-708.
19. Banfi, S., Servadio, A., Chung, M., Capozzoli, F., Duvick, L.A., Elde, R., Zoghbi, H.Y. and Orr, H.T. (1996) Cloning and developmental expression analysis of the murine homolog of the spinocerebellar ataxia type 1 gene (Scal). Hum. Mol. Genet., 5, 33-40.
20. Tusher, V.G., Tubshirani, R. and Chu, G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. USA, 98, 5116-5121.
21. The Gene Ontology Consortium (2006) The Gene Ontology (GO) project in 2006. Nucleic Acids Res., 34, D322-D326.
22. Dennis, G. Jr, Sherman, B.T., Hosack, D.A., Yang, J., Gao, W., Lane, H.C. and Lempicki, R.A. (2003) DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol., 4, 3. P.
23. Lomberk, G. and Urrutia, R. (2005) The family feud: Turning off Sp1 by SpI-like KLF proteins. Biochem J., 392, 1-11.
24. Balmer, J.E. and Blomhoff, R. (2002) Gene expression regulation by retinoic acid. J. Lipid Res., 43, 1773-1808.
25. Lein, E.S., Hawrylycz, M.J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A.F., Boguski, M.S., Brockway, K.S., Byrnes, E.J. et al. (2007) Genome-wide atlas of gene expression in the adult mouse brain. Nature, 445, 168-176.
26. Burright, E.N., Clark, H.B., Servadio, A., Matilla, T., Feddersen, R.M., Yunis, W.S., Duvick, L.A., Zoghbi, H.Y. and Orr, H.T. (1995) SCA1 transgenic mice: A model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell, 82, 937-948.
27. Vig, P.J., Subramony, S.H., Burright, E.N., Fratkin, J.D., McDaniel, D.O., Desaiah, D. and Qin, Z. (1998) Reduced immunoreactivity to calcium-binding proteins in Purkinje cells precedes onset of ataxia in spinocerebellar ataxia-1 transgenic mice. Neurology, 50, 106-113.
28. Dziedzicka-Wasylewska, M. and Solich, J. (2004) Neuronal cell lines transfected with the dopamme D2 receptor gene promoter as a model for studying the effects of antidepressant drugs. Mol. Brain Res., 128, 75-82.
29. de Chiara, C., Menon, R.P., Dal Piaz, F., Calder, L. and Pastore, A. (2005) Polyglutamine is not all: The functional role of the AXH domain in the ataxin-1 protein. J. Mol. Biol., 354, 883-893.
30. Yajima, S., Lee, S.H., Minowa, T. and Mouradian, M.M. (1998) Sp family transcription factors regulate expression of rat D2 dopamine receptor gene. DNA Cell Biol., 17, 471-479.
31. Sampson, E.M., Haque, Z.K., Ku, M.C., Tevosian, S.G., Albanese, C., Pestell, R.G., Paulson, K.E. and Yee, A.S. (2001) Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1. EMBO J., 20, 4500-4511.
32. Ciani, L. and Salinas, P.C. (2005) WNTs in the vertebrate nervous system: From patterning to neuronal connectivity. Nat. Rev. Neurosci. 6, 351-362.
33. Glover, J.C., Renaud, J.S. and Rijli, F.M. (2006) Retinoic acid and hindbrain patterning. J. Neurobiol., 66, 705-725.
34. Pak, J.H., Huang, F.L., Li, J., Balschun, D., Reymann, K.G., Chiang, C., Westphal, H. and Huang, K.P. (2000) Involvement of neurogranin in the modulation of calcium/calmodulin-dependent protein kinase II, synaptic plasticity, and spatial learning: A study with knockout mice. Proc. Natl Acad. Sci. USA, 97, 11232-11237.
35. Neve, K.A., Seamans, J.K. and Trantham-Davidson, H. (2004) Dopamine receptor signaling. J. Recept. Signal Transduct. Res., 24, 165-205.
36. Fowler, S.C., Zarcone, T.J., Vorontsova, E. and Chen, R. (2002) Motor and associative deficits in D2 dopamine receptor knockout mice. Int. J. Dev. Neurosci., 20, 309-321.
37. Draper, I., Kurshan, P.T., McBride, E., Jackson, F.R. and Kopin, A.S. (2007) Locomotor activity is regulated by D2-like receptors in Drosophila: An anatomic and functional analysis. Dev. Neurobiol. 67, 378-393.
38. Schweighofer, N., Doya, K. and Kuroda, S. (2004) Cerebellar aminergic neuromodulation: Towards a functional understanding. Brain Res. Rev. 44, 103-116.
39. Snider, R.S., Maiti, A. and Snider, S.R. (1976) Cerebellar pathways to ventral midbrain and nigra. Exp. Neurol., 53, 714-728.
40. Perciavalle, V., Berretta, S. and Raffaele, R. (1989) Projections from the intracerebellar nuclei to the ventral midbrain tegmentum in the rat. Neuroscience, 29, 109-119.
41. Kawaguchi, S.Y. and Hirano, T. (2002) Signaling cascade regulating long-term potentiation of GABA(A) receptor responsiveness in cerebellar Purkinje neurons. J. Neurosci., 22, 3969-3976.
42. An, J.J., Dae, M.H., Cho, S.R., Lee, S.H., Choi, S.H., Lee, B.H., Shin, H.S., Kim, Y.N., Park, K.W., Borrelli, E. et al. (2004) Altered GABAergic neurotransmission in mice lacking dopamine D2 receptors. Mol. Cell Neurosci., 25, 732-741.
43. Delis, F., Mitsacos, A. and Giompres, P. (2004) Dopamine receptor and transporter levels are altered in the brain of Purkinje Cell Degeneration mutant mice. Neuroscience, 125, 255-268.
44. Chen, Y.W., Allen, M.D., Veprintsev, D.B., Lowe, J. and Bycroft, M. (2004) The structure of the AXH domain of spinocerebellar ataxin-1. J. Biol. Chem., 279, 3758-3765.
45. Weeks, R.A., Piccini, P., Harding, A.E. and Brooks, D.J. (1996) Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease. Ann. Neurol., 40, 49-54.
46. Augood, S.J., Faull, R.L. and Emson, P.C. (1997) Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease. Ann. Neurol., 42, 215-221.
47. Dunah, A.W., Jeong, H., Griffin, A., Kim, Y.M., Standaert, D.G., Hersch, S.M., Mouradian, M.M., Young, A.B., Tanese, N. and Krainc, D. (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science, 296, 2238-2243.
48. Zhai, W., Jeong, H., Cui, L., Krainc, D. and Tjian, R. (2005) In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets. Cell, 123, 1241-1253.
49. Cummings, D.M., Milnerwood, A.J., Dallerac, G.M., Waights, V., Brown, J.Y., Vatsavayai, S.C., Hirst, M.C. and Murphy, K.P. (2006) Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of huntington's disease. Hum. Mol. Genet., 15, 2856-2868.
50. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
51. Jiang, C., Xuan, Z., Zhao, F. and Zhang, M.Q. (2007) TRED: A transcriptional regulatory element database, new entries and other development. Nucleic Acids Res., 35, D137-D140.
52. Vlieghe, D., Sandelin, A., De Bleser, P.J., Vleminckx, K., Wasserman, W.W., van Roy, F. and Lenhard, B. (2006) A new generation of JASPAR, the open-access repository for transcription factor binding site profiles. Nucleic Acids Res., 34, D95-D97.
53. Sandelin, A., Wasserman, W.W. and Lenhard, B. (2004) ConSite: Web-based prediction of regulatory elements using cross-species comparison. Nucleic Acids Res., 32, W249-W252.
54. Servadio, A., Koshy, B., Armstrong, D., Antalffy, B., Orr, H.T. and Zoghbi, H.Y. (1995) Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nature Genet., 10, 94-98.
55. Sala, A., Saitta, B., De Luca, P., Cervellera, M.N., Casella, I., Lewis, R.E., Watson, R. and Peschle, C. (1999) B-MYB transactivates its own promoter through SP1-binding sites. Oncogene, 18, 1333-1339.
56. Lee, F.J., Wang, Y.T. and Liu, F. (2005) Direct receptor cross-talk can mediate the modulation of excitatory and inhibitory neurotransmission by dopamine. J. Mol. Neurosc., 26, 245-252.